PMGC Inc.

ELAB | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.39

-$0.03 (-0.68%)

Sep 22, 2026, 2:43 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.68%

(1D)

Rating

Updated: Sep 2, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.99M

1D Range

4.13 4.52

52W Range

4.13 2,671.20

Valuation (TTM)

PE -0.02

PB 0.12

EV/EBITDA 0.24

Valuation (NTM)

Forward PE N/A

Forward PEG -0.00

Price Target N/A

Cash Flow

FCF Yield -447.4%

SBC Adj. FCF Yield -456.1%

SBC Impact -1.9%

Margins

Gross Margin 10.3%

Operating Margin -477.0%

FCF Margin -348.4%

Growth (CAGR)

Revenue 3Y | 5Y 35.8% | 26.0%

Dil EPS 3Y | 5Y 121.9% | -52.3%

FCF 3Y | 5Y -20.9% | -40.6%

Returns

ROA -36.9%

ROE -118.1%

ROIC -39.7%

Financial Health

Net Cash

$4.88M

Current Ratio 1.36

Interest Coverage -5.56

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering eng...

Sector Healthcare

Industry Biotechnology

Employees 33

IPO Date Nov 20, 2023

Website pmgcholdings.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.